WO2005059094A3 - Novel methods of inorganic compound discovery and synthesis - Google Patents
Novel methods of inorganic compound discovery and synthesis Download PDFInfo
- Publication number
- WO2005059094A3 WO2005059094A3 PCT/US2004/029480 US2004029480W WO2005059094A3 WO 2005059094 A3 WO2005059094 A3 WO 2005059094A3 US 2004029480 W US2004029480 W US 2004029480W WO 2005059094 A3 WO2005059094 A3 WO 2005059094A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- synthesis
- inorganic compound
- novel methods
- methods
- compound discovery
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1048—SELEX
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
Abstract
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US50239403P | 2003-09-12 | 2003-09-12 | |
US60/502,394 | 2003-09-12 | ||
US10/937,524 US20050136439A1 (en) | 2003-09-12 | 2004-09-09 | Novel methods of inorganic compound discovery and synthesis |
US10/937,524 | 2004-09-09 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2005059094A2 WO2005059094A2 (en) | 2005-06-30 |
WO2005059094A3 true WO2005059094A3 (en) | 2009-04-02 |
Family
ID=34681336
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2004/029480 WO2005059094A2 (en) | 2003-09-12 | 2004-09-10 | Novel methods of inorganic compound discovery and synthesis |
Country Status (2)
Country | Link |
---|---|
US (1) | US20050136439A1 (en) |
WO (1) | WO2005059094A2 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080206877A1 (en) * | 2007-02-22 | 2008-08-28 | The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of | Reactors for selective enhancement reactions and methods of using such reactors |
EA201291001A1 (en) * | 2010-04-16 | 2013-09-30 | Зиус Сайентифик, Инк. | METHODS OF MEASUREMENT OF ENZYMATIVE ACTIVITY, USEFUL WHEN DETERMINING THE VIABILITY OF CELLS IN UNCLEANED SAMPLES |
WO2015031799A1 (en) * | 2013-08-30 | 2015-03-05 | The Regents Of The University Of California, A California Corporation | Scintillator nanocrystal-containing compositions and methods for their use |
CN104923777A (en) * | 2015-03-18 | 2015-09-23 | 华南理工大学 | High-salt-tolerance metal nanoparticle assembly and preparing method thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7041451B2 (en) * | 1999-10-05 | 2006-05-09 | Sanofi-Aventis | Electrochemiluminescence helicase assay |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5705337A (en) * | 1990-06-11 | 1998-01-06 | Nexstar Pharmaceuticals, Inc. | Systematic evolution of ligands by exponential enrichment: chemi-SELEX |
US5637459A (en) * | 1990-06-11 | 1997-06-10 | Nexstar Pharmaceuticals, Inc. | Systematic evolution of ligands by exponential enrichment: chimeric selex |
US5723289A (en) * | 1990-06-11 | 1998-03-03 | Nexstar Pharmaceuticals, Inc. | Parallel selex |
US5580972A (en) * | 1993-06-14 | 1996-12-03 | Nexstar Pharmaceuticals, Inc. | Purine nucleoside modifications by palladium catalyzed methods |
US5719273A (en) * | 1993-06-14 | 1998-02-17 | Nexstar Pharmaceuticals, Inc. | Palladium catalyzed nucleoside modifications methods using nucleophiles and carbon monoxide |
US5428149A (en) * | 1993-06-14 | 1995-06-27 | Washington State University Research Foundation | Method for palladium catalyzed carbon-carbon coulping and products |
US20030099945A1 (en) * | 1994-09-20 | 2003-05-29 | Invenux, Inc. | Parallel selex |
EP1163052B1 (en) * | 1999-02-23 | 2010-06-02 | Caliper Life Sciences, Inc. | Manipulation of microparticles in microfluidic systems |
-
2004
- 2004-09-09 US US10/937,524 patent/US20050136439A1/en not_active Abandoned
- 2004-09-10 WO PCT/US2004/029480 patent/WO2005059094A2/en active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7041451B2 (en) * | 1999-10-05 | 2006-05-09 | Sanofi-Aventis | Electrochemiluminescence helicase assay |
Also Published As
Publication number | Publication date |
---|---|
WO2005059094A2 (en) | 2005-06-30 |
US20050136439A1 (en) | 2005-06-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2534891A1 (en) | Novel compounds having an antibacterial activity | |
WO2003093269A3 (en) | Substituted pyrazolo-pyrimidine-4-ones | |
AU3623800A (en) | Methods and compositions for economically synthesizing and assembling long dna sequences | |
DK1709056T3 (en) | phosphoramidate | |
EP1671998A3 (en) | Process to form compound with indolocarbazole moieties | |
WO2005108411A3 (en) | Substituted pixyl protecting groups for oligonucleotide synthesis | |
WO2005037198A3 (en) | Preparation of 1,7-disubstituted azabenzimidazoles as kinase inhibitors | |
WO2003016321A3 (en) | Novel phosphite compounds and novel phosphite metal complexes | |
WO2005084305A3 (en) | Flavonoids | |
WO2004063289A3 (en) | Surface modification of carbonaceous materials with tri substituted aminoalkyl substituents | |
WO2004084453A3 (en) | METHODS OF MANUFACTURE OF 2'-DEOXY-β-L-NUCLEOSIDES | |
WO2003046200A3 (en) | Methods for ligand discovery | |
WO2006066950A3 (en) | Tricyclic aminoalcohols, methods for producing the same and their use as anti-inflammatory agents | |
WO2007047671A3 (en) | Tetrahydroquinolines, synthesis thereof, and intermediates thereto | |
WO2004099197A3 (en) | Substituted oxyarenes, and use thereof for controlling pests | |
WO2007023342A3 (en) | Process of making geminal bisphosphonic acids and pharmaceutically acceptable salts and/or hydrates thereof | |
EP2039693A3 (en) | Novel synthesis of irbesartan | |
WO2005040107A3 (en) | Methods for making simvastatin and intermediates | |
WO2003012100A3 (en) | Method for the production of nucleic acids consisting of stochastically combined parts of source nucleic acids | |
WO2007016029A3 (en) | Diazepinoquinolines, synthesis thereof, and intermediates thereto | |
ATE466656T1 (en) | MICRO-ENCAPSULATION SYSTEM AND USES THEREOF | |
WO2002030870A3 (en) | Substituted c-cyclohexylmethylamine derivatives | |
WO2005059094A3 (en) | Novel methods of inorganic compound discovery and synthesis | |
WO2004048380A8 (en) | Process for the synthesis of ganciclovir | |
CA2453382A1 (en) | Mannitol and glucitol derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |